Search results
Novavax Reports First Quarter 2024 Financial Results and Operational Highlights
FOX 4 Kansas City· 3 days ago...multi-billion dollar revenue opportunity for Novavax including:$500 million upfront payment Approximately $70 million equity investment in NovavaxUp to $700 million in COVID-19 and combination product near-term milestones, plus ongoing tiered royalties on product salesUp to $200 million in...
Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Investor's Business Daily· 5 days agoThe RS Rating measures a stock's 12-month running performance against all other stocks. That RS...
Stocks Pause On Dismal Consumer Confidence; Yields, Dollar Rise As Inflation Expectations Kick...
Benzinga via Yahoo Finance· 2 days agoEditor’s note: This story has been updated to correct an error in the price action of Charter...
7 Stocks to Buy Before the Next ‘Great Reset’ Begins in 2024
InvestorPlace· 5 days agoAlimentation Couche-Tard (OTCMKTS:ANCTF) is a Canadian retail company with a network of convenience...
Dow Jones Today: Dow Extends Winning Streak to Eight Days as Major Indexes Gain For Third...
Investopedia· 2 days agoThe manufacturer of scales and other precision instruments topped sales and profit estimates,...
3 Profitable Dividend Stocks to Buy at Near-Lows
InvestorPlace· 4 days agoWith high yields above 3% and dirt-cheap valuations, these undervalued dividend stocks present a significant margin of safety.
US STOCKS-Wall St mixed but set for weekly gains ahead of inflation data
Reuters via Yahoo Finance· 3 days agoU.S. stock indexes were mixed on Friday, but looked on track for weekly gains ahead of key inflation readings next week that could provide more clues on how soon the Federal Reserve will start ...
The 3 Most Undervalued Healthcare Stocks to Buy in May 2024
InvestorPlace· 3 days agoA commonly used strategy for investing is sector rotation. A good example is the flow of funds into...
Opko Health (OPK) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 5 days agoIn oncology, we are pleased with GenPath's performance due to its innovative testing platform with an expanded hematological malignancy panel and very...
Earnings call: McKesson reports strong Q4 growth, optimistic FY 2025 outlook By Investing.com
Investing.com· 5 days agoThe company's strategic growth in oncology and biopharma services, coupled with its commitment to...
